BA vs ZNTL · P/E 89, rev $24.56B vs $257.7M cap
The Boeing Company (BA) versus Zentalis Pharmaceuticals Llc (ZNTL) — a side-by-side from cached financials, not a winner call.
The Boeing Company (BA) is a aerospace & defense company listed on NYSE. It is led by Robert K. Ortberg.
Zentalis Pharmaceuticals Llc (ZNTL) is a biotechnology company listed on NASDAQ.
Latest reported BA revenue for 2026-06-30 was $24.56B. Net income was -$444.0M. Revenue was up 10.5% from 2026-03-31 to 2026-06-30. BA currently screens at market cap $177.86B and trailing P/E 89.2.
Latest reported ZNTL revenue for 2025-09-30 was $0. Net income was -$26.7M. ZNTL currently screens at market cap $257.7M.
BA currently screens at market cap $177.86B and trailing P/E 89.2. ZNTL currently screens at market cap $257.7M.
Not investment advice. Open the BA and ZNTL stock pages for the full models.
Not investment advice.